Market - Page 4 of 314 - Express Pharma

Navigating the changing pharma landscape with innovation

Funding in pharma falls in September 2024, reaches $189 mn

Biocon Biologics refinances $ 1.1 bn long-term debt through USD bonds and new syndicated facility

Gilead Sciences signs licencing agreements with six companies to manufacture, commercialise Lenacapavir

Revenues to increase by 9-11 % for Indian pharma companies in FY2025: ICRA

Venus Remedies gets marketing authorisations for oncology drugs from Morocco, Philippines

Ind-Ra forecasts weak API prices and volume growth for India in FY25

Pharma sector set for 8-10 per cent revenue growth this fiscal

Atopic Dermatitis: A hotspot for innovation and investment opportunities, says GlobalData

Radiopharmaceuticals for prostate cancer to go nuclear with $6.3 bn in sales by 2030